Our Focus
Climbing mountains with AI
Montai was founded on the premise that advances in AI can help scientists think differently about how to match the right chemistry to the right biology.
The goal: solve persistent challenges in medicine with small molecule solutions, starting with chronic inflammatory diseases, enabling broad patient access to truly disease-modifying therapies.
Reaching new peaks
Moving beyond biologics
We envision a world where safe, convenient pills can replace costly injections and infusions — and where diseases that have no good treatment finally do.
Biology is complex; our tools have been too narrow
- 25+ validated targets for chronic inflammatory diseases, with no oral medicines that effectively address them
- The industry’s focus on structural biology has limited the ability to find small molecule solutions for these targets
- The slow, expensive, and unpredictable approach to conventional drug discovery means too many diseases are left untreated
Too many people are left untreated
- ~200M people diagnosed with chronic inflammatory diseases globally
- 97% are not receiving the most advanced therapies, most of which are expensive biologics
- 20% of diagnosed patients remain untreated
The mountains we climb
Combining human expertise with AI navigation, our mission is to climb some of medicine’s steepest peaks to discover accessible, effective drugs for chronic inflammatory diseases.
Montai aims to improve access to powerful therapies by developing transformative oral medicines that can match or exceed the performance of today’s biologics.
We work every day with the highest sense of urgency knowing patients are waiting for better options.


